They found co-expression of PD-1, LAG-3, TIM-3, LAG-3 and CTLA-4 on TILs in early stage BC samples and increased presence of LAG-3, PD-1, and TIGIT on CD8+ TIL in T2 tumors [88]. Here, CTLA4 is linked to breast cancer.